4//SEC Filing
Pfeffer Cary 4
Accession 0000899243-21-009484
CIK 0001640455other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:09 PM ET
Size
7.4 KB
Accession
0000899243-21-009484
Insider Transaction Report
Form 4
Pfeffer Cary
Director
Transactions
- Sale
Common Stock
2021-03-01−0→ 0 total(indirect: See Footnote)
Holdings
- 0(indirect: See Footnote)
Common Stock
- 9,917
Common Stock
Footnotes (4)
- [F1]On March 1, 2021, Third Rock Ventures II, L.P. ("TRV II") sold 1,450,000 shares of Common Stock of the Issuer at a price per share of $11.75.
- [F2]After the above transaction, TRV II owned 7,750,349 shares of Common Stock of the Issuer.
- [F3]The Reporting Person is a partner of Third Rock Ventures GP II, L.P., which is the general partner of TRV II. The Reporting Person disclaims beneficial ownership over the shares held by TRV II, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]Third Rock Ventures III, L.P. ("TRV III") directly holds 3,048,780 shares of the Issuer's Common Stock. The Reporting Person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001591092
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:09 PM ET
- Size
- 7.4 KB